Skip to content

The Emotional Impact of Surveillance for Pancreatic Cancer

Surveillance Program in High-risk Individuals for Pancreatic Cancer: Prospective Analysis of the Emotional Impact

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04024345
Enrollment
150
Registered
2019-07-18
Start date
2017-07-01
Completion date
2021-12-31
Last updated
2020-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer, Psychological Distress

Brief summary

Due to its rarity a population screening program for pancreatic cancer is not possible. For this reason, considering background data on genetic predisposition and familiarity for this lethal tumor, efforts have been pushed to build up surveillance programs for subjects at high-risk of pancreatic cancer, due to familiarity and/or genetic predisposition. These programs are based on radiological examinations (such as MRI or endoultrasonography) and laboratory tests. However, little is known about the psychological burden of these programs. Only a handful of studies investigated, in various ways, how the participation in surveillance programs for pancreatic cancer may burden the psychological status, with a consequent possible impairment of the psychological wellbeing, and a higher risk of withdraw from the surveillance program itself. The aim of this study was to assess the psychological and emotional impact in high-risk individuals participating in a surveillance program for pancreatic cancer due to familiarity and/or to genetic predisposition, using specific psychological tools, such as multiple psychological questionnaires, investigating different functioning areas, administered by a clinical psychologist.

Interventions

DIAGNOSTIC_TESTBarratt Simplified Measure of Social Status (BSMSS)

Questionnaire that evaluates cultural identity, educational level and occupation of the subject and the subject's parents and spouse (if any)

DIAGNOSTIC_TESTGlobal Assessment of Functioning scale (GAF)

Used to measure overall levels of functionality of an individual

DIAGNOSTIC_TESTGeneral Self-Efficacy Scale (GSES)

Psychometric scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life

To assess the perceived stress

DIAGNOSTIC_TESTCoping Orientation to Problems Experienced (Brief COPE),

It evaluates the subject's coping style through investigation of problem-solving abilities and emotional fluctuation, as a response to stressful situations

DIAGNOSTIC_TESTMultidimensional Scale of Perceived Social Support (MSPSS)

to explore the subject's social support system

Sponsors

Azienda Ospedaliera Universitaria Integrata Verona
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Being enrolled in the Institutional surveillance program for pancreatic cancer * Ability to understand the details and implications of a study protocol.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Barratt Simplified Measure of Social StatusBaselineEvaluation of cultural identity, educational level and occupation of the subject and the subject's parents and spouse (if any)
Global Assessment of Functioning scaleBaselinemeasure overall levels of functionality of an individual
General Self-Efficacy ScaleBaselineSelf-report scale correlated to emotion, optimism, work
Perceived Stress ScaleBaselineAssessment of the perceived stress
Coping Orientation to Problems ExperiencedBaselineevaluation of the subject's coping style through investigation of problem-solving abilities and emotional fluctuation, as a response to stressful situations
Multidimensional Scale of Perceived Social SupportBaselineto explore the subject's social support system

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026